<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01162525</url>
  </required_header>
  <id_info>
    <org_study_id>pTNS</org_study_id>
    <nct_id>NCT01162525</nct_id>
  </id_info>
  <brief_title>Percutaneous Tibial Nerve Stimulation for Patients With Fecal Incontinence</brief_title>
  <official_title>Percutaneous Tibial Nerve Stimulation (pTNS) for Patients With Fecal Urge Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cantonal Hospital of St. Gallen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cantonal Hospital of St. Gallen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Percutaneous tibial nerve stimulation is introduced as regular treatment option for fecal&#xD;
      urge continence at the Cantonal Hospital St. Gallen. During this introduction phase&#xD;
      efficiency und adverse events will be monitored in this observational study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Before treatment patients will have a proctological exam, a proctoscopy, endosonography and&#xD;
      anorectal manometry. Incontinence scores (Wexner, Vaizey, Hanley) and quality of life scores&#xD;
      (FIQL, VAS) will be recorded.&#xD;
&#xD;
      Treatment consists of 4 phases with decreasing frequency of percutaneous tibial nerve&#xD;
      stimulations (pTNS).&#xD;
&#xD;
      During phase 1 weekly stimulations of 30 mins are applied for 12 weeks. After 6 and 12 weeks&#xD;
      incontinence scores are recorded. Additionally after the end of phase 1 quality of life is&#xD;
      measured and an anorectal manometry is preformed.&#xD;
&#xD;
      Phase 2 lasts for 8 weeks, with 2-3 stimulations/month Phase 3 lasts for 8 weeks, with&#xD;
      stimulations every 3 weeks Phase 4 consists of one stimulation in one month.&#xD;
&#xD;
      After phase 4 incontinence scores und quality of life are measured.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fecal Incontinence</measure>
    <time_frame>6 weeks</time_frame>
    <description>Jorge Wexner Score (Dis Colon Rectum (1993) 36:77) compared to pretreatment&#xD;
Score for fecal incontinence, with 5 items and score range of 0 - 20</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal Incontinence</measure>
    <time_frame>12 weeks</time_frame>
    <description>Jorge Wexner Score (Dis Colon Rectum (1993) 36:77) compared to pretreatment&#xD;
Score for fecal incontinence, with 5 items and score range of 0 - 20</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal Incontinence</measure>
    <time_frame>32 weeks</time_frame>
    <description>Jorge Wexner Score (Dis Colon Rectum (1993) 36:77) compared to pretreatment&#xD;
Score for fecal incontinence, with 5 items and score range of 0 - 20</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fecal Incontinence</measure>
    <time_frame>before treatment, 6, 12, 32 wks after initial treatment</time_frame>
    <description>Vaizey Score (Gut (1999) 44:77)&#xD;
Fecal incontinence score similar to Wexner Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anorectal manometric measurements</measure>
    <time_frame>12 weeks</time_frame>
    <description>compared to pre-treatment values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>before treatment, 6, 32 wks after initial treatment</time_frame>
    <description>2 scores for quality of life are measured:&#xD;
Fecal Incontinence Quality of Life (FIQL) (Dis Colon Rectum (2000) 43:9)&#xD;
Visual Analogue Score Patients are asked to score their well-being in respect to the incontinence by marking a horizontal 10 cm line labelled &quot;extremely bad&quot; and &quot;excellent&quot; at both ends</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost</measure>
    <time_frame>at the end of the treatment</time_frame>
    <description>total cost of treatment will be evaluated (material, work hours etc)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>for each treatment interval</time_frame>
    <description>adverse events between treatments:&#xD;
pain, bleeding, neurological sensation, other AE&#xD;
Adverse events during percutaneous nerve stimulation:&#xD;
pain, bleeding and discomfort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary incontinence</measure>
    <time_frame>before treatment, 6, 12, 32 wks after initial treatment</time_frame>
    <description>Hanley Score (BMJ (2001) 322:1096)&#xD;
Urinary incontinence score</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Fecal Incontinence</condition>
  <arm_group>
    <arm_group_label>pTNS treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous tibial nerve stimulation (pTNS)</intervention_name>
    <description>A 34 gauge needle in placed close to the tibial nerve about 2-3 cm above the ankle. A self-adhesive surface electrode is placed on the skin. Needle and surface electrode are connected to an electric stimulator and the stimulating current (0 - 10 mA) is increased in 20 steps. When the patient feels a tingling sensation in the foot, stimulating current is set back for one step and the treatment is started (30 min stimulation).</description>
    <arm_group_label>pTNS treatment</arm_group_label>
    <other_name>pTNS</other_name>
    <other_name>peripheral tibial nerve stimulation</other_name>
    <other_name>peripheral neuromodulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  fecal urge incontinence&#xD;
&#xD;
          -  conservative treatment has been performed without success&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  current anticoagulation treatment&#xD;
&#xD;
          -  sphincter defects larger than 120Â°&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  pace maker&#xD;
&#xD;
          -  implanted defibrillators&#xD;
&#xD;
          -  severe heart disease&#xD;
&#xD;
          -  existing neurological damages&#xD;
&#xD;
          -  disposition for strong bleeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lukas T Marti, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Surgery, Cantonal Hospital St. Gallen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Surgery, Cantonal Hospital St. Gallen</name>
      <address>
        <city>St. Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.chirurgie.kssg.ch/home/unsere_klinik.html</url>
    <description>Website of the Department of Surgery, Cantonal Hospital of St. Gallen (German only)</description>
  </link>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>July 13, 2010</study_first_submitted>
  <study_first_submitted_qc>July 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2010</study_first_posted>
  <last_update_submitted>September 18, 2018</last_update_submitted>
  <last_update_submitted_qc>September 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cantonal Hospital of St. Gallen</investigator_affiliation>
    <investigator_full_name>Lukas Marti</investigator_full_name>
    <investigator_title>Attending physician</investigator_title>
  </responsible_party>
  <keyword>Fecal Incontinence</keyword>
  <keyword>Fecal Urge Incontinence</keyword>
  <keyword>Percutaneous tibial nerve stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fecal Incontinence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

